A detailed history of Alaska Permanent Fund Corp transactions in Organon & Co. stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 150,538 shares of OGN stock, worth $2.19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
150,538
Previous 150,538 -0.0%
Holding current value
$2.19 Million
Previous $3.12 Million 7.61%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$17.45 - $21.96 $62,261 - $78,353
3,568 Added 2.43%
150,538 $3.12 Million
Q1 2024

Apr 09, 2024

BUY
$13.78 - $18.8 $205,211 - $279,969
14,892 Added 11.28%
146,970 $2.76 Million
Q4 2023

Feb 01, 2024

BUY
$10.95 - $17.32 $158,534 - $250,758
14,478 Added 12.31%
132,078 $1.9 Million
Q2 2023

Jul 31, 2023

BUY
$19.27 - $24.63 $955,792 - $1.22 Million
49,600 Added 72.94%
117,600 $2.45 Million
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $2.15 Million - $2.65 Million
68,000 New
68,000 $2.3 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.